Lupin announces launch of world’s first FDC drug for chronic lung disease
Global pharma major Lupin on Thursday announced the launch of Vilfuro-G, the world’s first fixed-dose triple combination drug (FDC) for
Continue readingThe Number One Finance & Business Blog!
Global pharma major Lupin on Thursday announced the launch of Vilfuro-G, the world’s first fixed-dose triple combination drug (FDC) for
Continue readingAs US-based private equity (PE) firm Advent International completed the acquisition of a majority stake in Hyderabad-based Suven Pharma,
Continue readingDr. Reddy’s Laboratories (DRL) on Friday announced its entry into the generic drug business in India, with an aim to
Continue reading